Clinical Trial Update: Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating intra-tumoral injections of natural killer (NK) cells for recurrent malignant pediatric brain tumors has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Natural killer cells (natural killer cells)

Snippet

Sponsor: Sabine Mueller, MD, PhD | Conditions: Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor | Phase 1 | Status: SUSPENDED